SCHEMBL29497455

SCHEMBL29497455

CCc1ccc(C(F)F)c(OC2CCC3(CC2)CNC3)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25410707 1.00 — —
SCHEMBL30503568 0.81 CHRM4 (0.32) —
SCHEMBL26631463 0.81 CHRM4 (0.32) —
SCHEMBL29427075 0.79 — —
SCHEMBL25410315 0.79 — —
SCHEMBL29427106 0.77 PDE4D (0.37) —
SCHEMBL25412820 0.77 PDE4D (0.37) —
SCHEMBL29426927 0.76 CHRM4 (0.34) —
SCHEMBL26750427 0.76 CHRM2 (0.33) —
SCHEMBL26739485 0.76 CHRM4 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 — — US disclosed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 — — US disclosed
CN-116323557-A Cyclobutylamide monoacylglycerol lipase modulators 詹森药业有限公司 2023-06-23 — — CN disclosed
US-20220089538-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-03-24 — — US disclosed
Send feedback